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ABSTRACT
Background: Moderate acute malnutrition (MAM) affects 34.1 million children globally. Treatment effectiveness is
generally determined by the amount and rate of weight gain. Body composition (BC) assessment provides more detailed
information on nutritional stores and the type of tissue accrual than traditional weight measurements alone.
Objective: The aim of this study was to compare the change in percentage fat mass (%FM) and other BC parameters
among young Malian children with MAM according to receipt of 1 of 4 dietary supplements, and recovery status at the
end of the 12-wk intervention period.
Methods: BC was assessed using the deuterium oxide dilution method in a subgroup of 286 children aged 6–
35mowho participated in a 12-wk community-based, cluster-randomized effectiveness trial of 4 dietary supplements for
the treatment of MAM: 1) lipid-based, ready-to-use supplementary food (RUSF); 2) special corn–soy blend “plus plus”
(CSB++); 3) locally processed, fortified flour (MI); or 4) locally milled flours plus oil, sugar, and micronutrient powder
(LMF). Multivariate linear regression modeling was used to evaluate change in BC parameters by treatment group and
recovery status.
Results: Mean ± SD %FM at baseline was 28.6% ± 5.32%. Change in %FM did not vary between groups. Children
who received RUSF vs. MI gained more (mean; 95% CI) weight (1.43; 1.13, 1.74 kg compared with 0.84; 0.66, 1.03 kg;
P = 0.02), FM (0.70; 0.45, 0.96 kg compared with 0.20; 0.05, 0.36 kg; P = 0.01), and weight-for-length z score (1.23;
0.79, 1.54 compared with 0.49; 0.34, 0.71; P = 0.03). Children who recovered from MAM exhibited greater increases
in all BC parameters, including %FM, than children who did not recover.
Conclusions: In this study population, children had higher than expected %FM at baseline. There were no differences
in %FM change between groups. International BC reference data are needed to assess the utility of BC assessment
in community-based management of acute malnutrition programs. This trial was registered at clinicaltrials.gov as
NCT01015950. J Nutr 2019;149:1089–1096.
Keywords: acute malnutrition, anthropometry, body composition, child growth, Mali, supplementary feeding
Introduction
Globally, an estimated 50.5 million children <5 y of age
suffer from acute malnutrition (AM) (1). This condition is
characterized by wasting and can be further classified into
moderate and severe forms according to the child’s weight-for-
height z score (WHZ), mid-upper arm circumference (MUAC),
and/or the presence of bipedal edema (2). AM impairs immune
function, heightens susceptibility to infection, and increases the
risk of mortality (3, 4). Children with a WHZ < −3, and
between −2 and −3 are at 9.4 and 3.0 times higher risk of
death, respectively, than are children with a WHZ > −1 (5).
The burden of AM is particularly high in the Sahel region of
Africa. In 2013, an estimated 385,000 children<5 y of age were
believed to be living with moderate acute malnutrition (MAM)
in Mali (6).
Community-based management of acute malnutrition
(CMAM) is a comprehensive system for the prevention,
screening, diagnosis, and treatment of different forms of AM
in a community setting (3). In Mali, children with MAM are
typically treated as outpatients, using appropriate medicines
and either processed food blends, such as super cereal plus,
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or dietary counseling on the use of locally available cereal–
legume blends and a mixture of vitamins and minerals
(7). However, lipid-based nutrient supplements (LNSs) and
improved formulations of cereal–legume blends have recently
been proposed as superior treatment approaches given their
enhanced nutrient profile and ease of preparation (8).
In addition to the growing recognition that treatment
strategies must be tailored to meet the specific nutritional needs
of children with MAM (9), there is increasing awareness that
multiple issues must be considered when determining whether
a dietary intervention is effective. The child’s amount and rate
of weight gain or change in MUAC are often the only outcomes
that are considered when evaluating whether an intervention
has succeeded in treating a child with AM. However, weight
gain alone does not necessarily imply an improvement in
health status. The measurement of body composition (BC) is
an important part of pediatric nutritional assessment because
it provides more detailed information on a child’s nutritional
stores and the type of tissue that has been accrued. However,
BC is seldom assessed in the context of CMAM programs.
Furthermore, there have been few investigations on the effects
of newly designed dietary products on the BC of children with
MAM.
We previously reported the results of a cluster-randomized,
community-based effectiveness trial of 4 different dietary
supplements on growth and recovery from MAM among
young Malian children (10). The objectives of the study
were to compare the change in percentage fat mass (%FM)
and other BC parameters according to the type of dietary
supplement received, and recovery status at the end of the
12-wk intervention period in a subgroup of trial
participants.
Methods
Study design and participants
The study (Management of Children withModerate AcuteMalnutrition
in Mali—NCT01015950) was designed as a cluster-randomized,
community-based effectiveness trial. Given the different physical
characteristics of the 4 supplements, the trial was not able to be masked.
Detailed methods of the trial have been published previously (10).
Briefly, the parent study was conducted in 12 of the 20 community
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health centers (CSComs) in the health district of Dioila, which is
∼170 km southeast of Bamako, Mali. Average daily high temperatures
in this region typically range from 31◦C in August to 40◦C in April.
Although all children<5 y of age are eligible to receive treatment for
AM in Mali, our study was restricted to children 6–35 mo of age, given
the relatively higher prevalence of wasting in this subgroup and our
desire to limit variability in the expected growth outcomes. Bimonthly
community-based screenings were conducted between May, 2010 and
May, 2011 to identify potential study participants. Children were
identified as having MAM using 2 sets of criteria. The first set of criteria
was based on the 2006 WHO Growth Standards: a weight-for-length z
score (WLZ) < −2 and ≥ −3, or MUAC <12.5 cm and ≥11.5 cm (11).
The second set of criteria was based onMali’s national norms at the time
of the study: weight-for-length <80th percentile and ≥70th percentile
of the National Center for Health Statistics median, or MUAC <12.0
and ≥11.0 cm (7). All children who met either set of criteria and did
not have edema during the screening were referred to the CSCom for
possible study enrollment. Children who were confirmed as fulfilling
the eligibility criteria during the clinic-based assessment were invited to
participate in the trial, and written informed consent was sought from
the child’s parent. Children with severe anemia (hemoglobin <50 g/L),
severe acute malnutrition (SAM) [WLZ < −3 based on the 2006 WHO
Growth Standards (4), weight-for-length <70th percentile based on the
National Center for Health Statistics median, MUAC <11.0 cm], or
other illnesses requiring inpatient treatment were referred for medical
care and excluded from the study. We also excluded children with
congenital abnormalities; underlying chronic diseases, including known
HIV infection; or a history of allergy to peanuts or previous serious
allergic reactions requiring emergency medical care. Long distances
between CSComs, logistical and financial constraints, and the need to
collect samples in the morning hours prevented us from conducting
the BC substudy in all 12 CSComs. Therefore, we enrolled into the
BC substudy a subsample of study children that were enrolled in the
8 CSComs nearest to the district hospital.
All 8 CSComs were stratified according to their distance from the
main village of Dioila and population density, then randomly assigned to
1 of 4 dietary interventions within each stratum at the beginning of the
study, and then were randomly reassigned, within stratum, to a different
dietary group after the first 3 rounds of screening. All study children
reporting to a particular CSCom received the same dietary supplement
during each round.
Study interventions
The 4 food supplements provided were: 1) ready-to-use supplementary
food (RUSF; supplied by Nutriset) called “Supplementary Plumpy” at
the time of the study, but renamed to Plumpy’Sup since then; 2) corn–soy
blend “plus plus” (CSB++; supplied by the World Food Programme),
a refined cereal–legume–milk blend containing dehulled soybean flour,
maize flour, dried skimmed milk, sugar, soya oil, and a micronutrient
premix that is designed for children with MAM and is very similar
to a current World Food Programme product known as Super Cereal
Plus; 3) Misola (MI; supplied by Misola, Mali), which is a locally
produced micronutrient-fortified cereal–legume blend that is less refined
than CSB++ and contains 60% millet or maize flour, 20% soy flour,
10% peanut flour, micronutrient premix, and amylase powder; and
4) a cereal–legume locally milled flours mix (LMF), also less refined
than CSB++, which was provided along with vitamin A–fortified oil
and multiple micronutrient powder sachets. All 4 dietary interventions
were distributed to participants at enrollment and each follow-up
visit throughout the 12-wk intervention period. The supplements were
supplied in a quantity to provide each child with 500 kcal/d until
the next scheduled visit. Caregivers were instructed to provide the
supplement in addition to the child’s usual home diet and not to share
the supplement with other family members.
Study procedures
In addition to receiving the dietary supplements, all study children
were treated according to Mali’s national CMAM protocol in place
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at the time of the study (7). All children received high-dose vitamin A
supplementation if they had not received a vitamin A supplement in
the previous 3 mo; anti-helminthic treatment; and specific ambulatory
treatment, as required, for malaria or other acute infections.
Background information on sociodemographic characteristics was
collected during the first patient encounter. At enrollment and at each
of the scheduled follow-up visits at the CSCom (i.e., 1, 2, 3, 4, 6, 8, 10,
and 12 wk after enrollment), the child’s weight was measured to the
nearest 20 g using the Seca 383 electronic baby and child scale (Seca),
length was measured to the nearest 0.1 cm using a Shorr Board (Shorr
Productions), and MUAC was measured to the nearest 0.1 cm with a
Shakir Strip (UNICEF Supply Division). Length-for-age (LAZ), weight-
for-age (WAZ), andWLZwere calculated using the 2006WHOGrowth
Standards (12).
BC assessment
The BC of subjects in the substudy was assessed at enrollment and at the
end of the 12-wk intervention period using the deuterium oxide (2H2O)
dilution technique. A baseline saliva sample of ≥2.5 mL was obtained
from the child by holding cotton swabs in the mouth and using a syringe
to express the absorbed saliva into two 3.6-mL Corning cryotubes. A
preweighed dose of 4.00 g 2H2O,with an isotopic enrichment of 99.8%
(Cambridge Isotope Laboratories), was then transferred from a vial
to a syringe and administered orally to the child. To ensure that the
entire dose of 2H2O was ingested by the child, the same syringe was
used to rinse the vial twice with 1.5 mL of pure water, which was then
administered to the child. Saliva samples were collected using the same
procedure as described above 2.5 and 3.5 h after the 2H2O dose was
administered. All saliva samples were temporarily stored in a portable
refrigerated cooler and then transferred to a −20◦C freezer at the end
of the day.
Children were allowed to breastfeed and to consume water, bananas,
and/or biscuits supplied by the study staff throughout the BC assessment
procedure. The amount of breast milk consumed was estimated by
weighing the child to the nearest 10 g with an electronic infant balance
(Seca 354) immediately before and after the feeding. The mass of food
or water consumed was estimated by weighing the amount served and
the uneaten portion with an electronic balance with 0.1-g precision
(MyWeigh Triton T2) and calculating the difference. The total water
intake was then calculated by multiplying the mass of each food or
liquid consumed by the water content of the particular food or liquid,
as reported in the USDA Food Composition Database (13), and then
summing all amounts and the amount of water used to rinse the 2H2O
vial.
The 2H2O enrichment of the duplicate saliva samples was analyzed
using Fourier Transform Infrared Spectroscopy at St. John’s Research
Institute in Bangalore, India. The 2H2O concentration of the baseline
predose saliva sample was subtracted from the postdose saliva sample
that had the highest 2H2O concentration. Total body water (TBW) was
calculated using the following equation:
TBW = [(2H2Odose/2H2Oenrichment) × 900 × 0.96 × 0.944]
−water intake (L), (1)
where 900 represents the molecular weight of 2H2O relative to
water, 0.96 represents the nonaqueous hydrogen exchange, and 0.944
represents the estimated fractionation of the isotope (14). Fat-free mass
(FFM) was calculated by dividing TBW by the proportion of water
in FFM, which we obtained from age- and sex-specific reference data
(15). Fat mass (FM) was then calculated as the difference between body
weight and FFM. FFM index (FFMI) and FM index (FMI) were also
calculated by dividing FFM and FM, respectively, by length squared.
The percentage of body weight as fat mass (%FM) was also calculated.
Sample size
We estimated that a sample size of 102 subjects per group was required
to detect an effect size of 0.5 SD units in the difference in the change
in FFM from baseline to 12 wk between groups, assuming a type I
error rate of 0.05, power of 80%, and 15% attrition rate. Based on
results from 2 previous studies of BC in young children in low-income
countries,we expected the specified effect size to translate to a difference
in the change in FFM of 0.17–0.28 kg. This effect size also corresponded
to a difference in the change in%FMof∼3.1 percentage points between
groups (16, 17).
Statistical analysis
All subjects with plausible BC data at both the enrolment visit and the
12-wk visit were included in the analysis. Descriptive statistics were
used to summarize maternal, socioeconomic, and child characteristics
according to treatment group at baseline. The mean ± SD was reported
for all BC and anthropometric measures at baseline and the Tukey–
Kramer test was used to detect any differences between groups. Paired
t tests were used to identify any differences in mean values for the
BC measures at baseline compared with 12 wk among all study
subjects.
We used generalized linear models to estimate the adjusted mean
change in all BC and anthropometric measures from baseline to the end
of the 12-wk intervention period, by study group. The Tukey–Kramer
test was used post hoc to identify any significant differences in the
adjusted means between groups. We also used mixed linear regression
models to compare the mean change in all BC and anthropometric
measures, adjusted for child age, sex, weight at baseline, and value of
the outcome variable at baseline, between children who had recovered
from MAM at the end of the 12-wk intervention period and those
who had not recovered. In these models, “recovery” was defined as a
WHZ ≥ −2 and a MUAC ≥12.5 cm. Finally, we conducted correlation
analyses and paired t tests to compare BC parameters among a subgroup
of children who had 2H2O and bioelectrical impedance analysis (BIA)
measurements available.
All statistical analyses were performed using SAS version 9.2 (SAS
Institute Inc.).
Ethics
The study protocol was approved by the Nutrition Division of the
Malian Ministry of Health and the Ethical Review Committees of the
University of Bamako Faculty of Medicine; University of California,
Davis; and Boston University.
Results
Of the 1284 children who were enrolled in the larger
effectiveness trial, 290 children attending the 8 CSComs nearest
to the district hospital were included in the BC substudy. This
represented ∼38% of the total number of children who were
enrolled in the main trial from these 8 CSComs. We excluded
1 child who did not have BC data available at both time
points and 3 children who had a %FM >40%, which we
deemed implausible and likely due to a methodological error
in assessment. This left 286 children who were included in all
analyses (Figure 1). As shown in Table 1, the vast majority
of mothers in all 4 groups were married housewives with no
formal education. The size of an average household exceeded
12 people, and most households used a bicycle as their primary
mode of transportation. Mean child age at random assignment
was ∼14.7 mo and just less than half of all participants were
male. Mean child MUAC and WLZ at baseline ranged from
11.9 to 12.2 cm and from −2.11 to −2.23, respectively, across
the 4 intervention groups. The distribution of most baseline
characteristics did not significantly vary between children who
were enrolled in the BC substudy and those who were not.
However, children enrolled in the BC substudy had a slightly
lower proportion of married mothers (96.5% compared with
98.6%; P= 0.02), their households owned fewer cows/goats on
average (14.1 ± 20.1 compared with 23.3 ± 46.7; P = 0.003),
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n = 7702
n = 1535
n = 1284
n = 344
n = 67
n = 64 n = 85 n = 82 n = 55
n = 86 n = 82 n = 55
n = 349 n = 307 n = 284
6–35
FIGURE 1 Profile for the BC substudy. AM, acute malnutrition; BC, body composition; CSB++, corn–soy blend “plus-plus”; LMF, locally milled
flours mix; MAM, moderate acute malnutrition; MI, Misola; RUSF, ready-to-use supplementary food; SAM, severe acute malnutrition.
and they exhibited higher mean LAZ and WAZ scores at
baseline (–2.16± 1.19 compared with –2.40± 1.30; P= 0.006,
and –2.76 ± 0.77 compared with –2.90 ± 0.86; P = 0.02,
respectively).
Table 2 shows themean± SD bodyweight, TBW,FM,%FM,
MUAC, and WLZ among all subjects at baseline and at the end
of the 12-wk intervention period. With the exception of %FM,
each parameter significantly increased over time (P < 0.0001).
FFM increased by a mean of 13.3% and FM increased by
17.1%.As shown inTable 3, there were significant differences in
TBW, FFM, and MUAC between groups at baseline (P < 0.05).
Multivariate analysis of change on the various BC parameters
from baseline to 12 wk indicated significant differences in the
amount of length, body weight, FM, FMI, WLZ, and MUAC
gained between groups. Pairwise comparisons revealed that
children in the RUSF group had greater gains in weight, FM,
FMI, and WLZ than children in the MI group (1.43 compared
with 0.84 kg, P = 0.02; 0.70 compared with 0.20 kg, P = 0.01;
0.89 compared with 0.10 kg/m2, P = 0.04; and 1.17 compared
with 0.57, P = 0.03, respectively) and children in the LMF
group demonstrated a greater increase in MUAC than children
in the MI group (1.24 compared with 0.57 cm; P = 0.008).
Finally, there was a nonsignificant trend towards increased
length gain among children in the CSB++ group compared with
the MI group (3.33 compared with 2.52 cm; P = 0.06).
Approximately two-thirds of children in the BC substudy
recovered from MAM by the end of the 12-wk intervention
(Table 4). Because “recovery” was defined by achieving a
WLZ ≥ −2 andMUAC ≥12.5 cm, it is not surprising that gains
in body weight, TBW, WLZ, and MUAC were all significantly
greater among recovered than among nonrecovered children
(P < 0.0001). However, the recovered children also exhibited
greater gains in FFM, FFMI, FM, FMI, %FM, and length
than did the non-recovered children (P < 0.0001). We also
observed that the recovered children had greater FM (2.02
compared with 1.87 kg; P = 0.002), but not %FM, at
baseline.
Among 190 study participants who had both 2H2O and BIA
measurements available, %FM values were correlated at both
time points (baseline: r = 0.22, P = 0.002; 12 wk: r = 0.30,
P< 0.0001). Although the mean%FM as measured by BIA was
1.3 percentage points lower than the mean %FM as measured
by 2H2O, at baseline (P = 0.01), there were no significant
differences in mean %FM at 12 wk.
Discussion
In this study of 286 young Malian children with MAM
treated for 12 wk, we observed a greater increase in body
weight, FM, FMI, and WLZ among children who received
daily supplementation with RUSF compared with MI, and a
greater increase in MUAC among children who received LMF
compared withMI. Although we did not identify any significant
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TABLE 1 Characteristics of study participants at baseline, by treatment group1
RUSF (n= 64) CSB++ (n= 85) Misola (n= 82) LMF (n= 55)
Maternal characteristics
No formal education 59 (93.7) 72 (84.7) 66 (80.5) 49 (89.1)
Can read or write 4 (6.1) 12 (14.1) 12 (14.6) 7 (12.7)
Profession
Housewife 56 (88.9) 57 (67.1) 58 (70.7) 45 (81.8)
Agriculture 3 (4.8) 25 (29.4) 19 (23.2) 8 (14.6)
Other 4 (6.4) 3 (3.5) 5 (6.1) 2 (3.6)
Married 63 (98.4) 81 (95.3) 81 (98.8) 51 (92.7)
Household socioeconomic characteristics
Number of people in the household/compound2 14.6 ± 9.6 13.9 ± 9.2 14.0 ± 8.2 12.7 ± 16.1
Number of cows/goats owned 6 [3, 13] 9 [3, 20] 8 [3, 16] 10 [5, 16]
Owns a radio 56 (88.9) 79 (92.9) 68 (82.9) 52 (94.6)
Mode of transportation
Walk 4 (6.4) 5 (6.0) 2 (2.4) 3 (5.8)
Bicycle 39 (61.9) 68 (81.0) 51 (62.2) 36 (69.2)
Motorcycle 17 (27.0) 11 (13.1) 27 (32.9) 12 (23.1)
Other 3 (4.8) 0 (0.0) 2 (2.4) 1 (1.9)
Minutes to primary water source 5 [3, 10] 5 [2, 10] 4 [2, 5] 5 [2, 10]
Child characteristics
Age at random assignment, mo 14.5 ± 7.2 15.8 ± 7.9 13.8 ± 6.6 14.7 ± 6.6
Male sex 33 (51.6) 40 (47.1) 30 (36.6) 25 (45.5)
Weight, kg 6.93 ± 1.22 7.23 ± 1.24 6.82 ± 0.99 7.16 ± 0.95
Length, cm 70.5 ± 6.7 72.3 ± 7.0 70.1 ± 5.3 71.6 ± 5.7
Mid-upper arm circumference, cm 11.9 ± 0.5 12.2 ± 0.5 12.0 ± 0.5 12.0 ± 0.5
Weight-for-length z score –2.20 ± 0.76 –2.23 ± 0.62 –2.23 ± 0.59 –2.11 ± 0.72
Length-for-age z score –2.39 ± 1.30 –2.09 ± 1.18 –2.15 ± 1.07 –2.04 ± 1.25
Weight-for-age z score –2.90 ± 0.85 –2.74 ± 0.72 –2.78 ± 0.73 –2.63 ± 0.80
1Values are mean ± SD, n (%), or median [IQR]; n = 286, unless otherwise noted. CSB++, corn–soy blend “plus-plus”; LMF, locally milled flours mix; RUSF, ready-to-use
supplementary food.
2A household was defined as a group of people who are primarily dependent on an individual person, currently eat from the same pot, and live under the same roof or in the
same compound.
differences in the change in%FMbetween groups, children who
recovered from MAM by the end of the intervention exhibited
greater gains in all BC parameters, including %FM. Our study
is one of the first to compare changes in BC as a response
to dietary supplementation in children with MAM in a low-
resource, community-based setting.
BC reference data are extremely limited for children <5 y of
age, which makes it challenging to compare the BC of our study
participants with that of healthy children (18). We observed
that although the mean TBW, FM, and FFM among all study
participants were expectedly lower than the corresponding
means in a cohort of 76 healthy US children of comparable age,
the mean %FM of 29% appears higher than reference mean
values, which range from 24.5% in 18-mo-old boys to 27.6%
in 12-mo-old girls (15). The same observation was made when
our findings were compared with reference values calculated
by Fomon et al. (19) in the early 1980s. The discrepancy in
%FM became even more pronounced when we compared our
data with recently published BC data from populations in other
resource-limited settings (20–22). We were able to confirm
that the relatively high %FM values observed in our study
population were not likely due to any methodological errors by
TABLE 2 Body composition of all study participants at baseline and the end of the 12-wk intervention1
Baseline Final Change P 2
Length, cm 71.1 ± 6.3 73.9 ± 6.0 2.73 ± 1.12 <0.001
Body weight, kg 7.03 ± 1.13 8.05 ± 1.30 1.02 ± 0.53 <0.0001
Total body water, kg 3.96 ± 0.73 4.47 ± 0.74 0.51 ± 0.38 <0.0001
FFM, kg 5.03 ± 1.10 5.70 ± 0.99 0.69 ± 0.53 <0.0001
FFMI,3 kg/m2 9.88 ± 0.86 10.4 ± 0.86 0.53 ± 0.90 <0.0001
FM, kg 1.99 ± 0.42 2.33 ± 0.54 0.33 ± 0.50 <0.001
FMI,4 kg/m2 3.97 ± 0.80 4.27 ± 0.84 0.30 ± 0.93 <0.0001
FM, % of body weight 28.6 ± 5.32 29.0 ± 4.79 0.36 ± 6.6 0.31
Mid-upper arm circumference, cm 12.1 ± 0.51 12.9 ± 0.75 0.84 ± 0.72 <0.0001
Weight-for-length z score –2.20 ± 0.66 –1.47 ± 0.83 0.73 ± 0.71 <0.0001
1Values are mean ± SD, n = 286, unless otherwise noted. FFM, fat-free mass; FFMI, fat-free mass index; FM, fat mass; FMI, fat mass index.
2Obtained from a paired t test.
3FFMI was calculated as FFM (in kilograms) divided by length (in meters), squared.
4FMI was calculated as FM (in kilograms) divided by length (in meters), squared.
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TABLE 3 Effect of dietary regimen on change in length and body composition of study participants over the 12-wk intervention1
RUSF (n= 64) CSB++ (n= 85) Misola (n= 82) LMF (n= 85) P 2
Baseline
Length, cm 70.5 ± 6.7 72.3 ± 7.0 70.1 ± 5.3 71.6 ± 5.7 0.11
Body weight, kg 6.93 ± 1.23 7.23 ± 1.24 6.82 ± 0.99 7.16 ± 0.95 0.08
TBW, kg 3.85 ± 0.82 4.08 ± 0.77 3.82 ± 0.65 4.12 ± 0.74 0.02
FFM, kg 4.88 ± 0.99 5.18 ± 1.05 4.84 ± 0.87 5.23 ± 0.98 0.03
FFMI,3 kg/m2 9.82 ± 0.82 9.84 ± 0.75 9.78 ± 0.76 10.2 ± 1.13 0.06
FM, kg 2.01 ± 0.43 2.04 ± 0.40 1.97 ± 0.35 1.92 ± 0.51 0.40
FMI,4 kg/m2 4.08 ± 0.73 3.94 ± 0.76 4.04 ± 0.70 3.79 ± 1.05 0.21
FM, % of body weight 29.3 ± 4.9 28.5 ± 4.8 29.2 ± 4.7 27.2 ± 7.0 0.10
WLZ –2.20 ± 0.76 –2.23 ± 0.62 –2.23 ± 0.59 –2.11 ± 0.72 0.74
MUAC, cm 11.9 ± 0.50a 12.2 ± 0.55b 12.0 ± 0.46a,b 12.0 ± 0.45a,b 0.009
Change from baseline to end of 12-wk intervention5
Length, cm 3.38 (2.80, 3.96) 3.33 (2.81, 3.85) 2.52 (2.16, 2.88) 2.94 (2.50, 3.37) 0.009
Body weight, kg 1.43 (1.13, 1.74)a 1.03 (0.76, 1.30)a,b 0.84 (0.66, 1.03)b 1.24 (1.01, 1.46)a,b 0.02
TBW, kg 0.66 (0.45, 0.88) 0.59 (0.40, 0.78) 0.45 (0.32, 0.58) 0.56 (0.40, 0.72) 0.32
FFM, kg 0.87 (0.59, 1.14) 0.76 (0.52, 1.01) 0.59 (0.43, 0.76) 0.74 (0.54, 0.94) 0.35
FFMI,3 kg/m2 0.68 (0.22, 1.14) 0.45 (0.04, 0.86) 0.52 (0.24, 0.79) 0.55 (0.22, 0.89) 0.21
FM, kg 0.70 (0.45, 0.96)a 0.19 (–0.03, 0.41)c 0.20 (0.05, 0.36)b,c 0.52 (0.34, 0.71)a,b 0.009
FMI,4 kg/m2 0.89 (0.43, 1.34)a –0.08 (–0.48, 0.32)c 0.10 (–0.17, 0.38)b,c 0.55 (0.22, 0.88)a,b 0.02
FM, % of body weight 2.88 (0.26, 5.50) –1.13 (–3.44, 1.18) –0.54 (–2.12, 1.04) 1.51 (–0.40, 3.41) 0.12
WLZ 1.23 (0.83, 1.63)a 0.54 (0.18, 0.90)a,b 0.49 (0.25, 0.74)b 0.99 (0.70, 1.28)a,b 0.02
MUAC, cm 1.17 (0.79, 1.54)a,b 0.87 (0.54, 1.21)a,b 0.57 (0.35, 0.80)b 1.24 (0.96, 1.51)a 0.01
1Values are mean ± SD, n = 286, unless otherwise noted. Groups were compared using unadjusted general linear models. Means in a row without a common letter are
significantly different (Tukey–Kramer test, P < 0.05). The only exception to this was the comparison in the mean change in FM between the RUSF and CSB++ groups, which
had a P value of 0.051. CSB++, corn–soy blend “plus-plus”; FFM, fat-free mass; FFMI, fat-free mass index; FM, fat mass; FMI, fat mass index; LMF, locally milled flours mix;
MUAC, mid-upper arm circumference; RUSF, ready-to-use supplementary food; TBW, total body water; WLZ, weight-for-length z score.
2P value reflects the Type III sum of squares for the treatment group in the model.
3FFMI was calculated as FFM (in kilograms) divided by length (in meters), squared.
4FMI was calculated as FM (in kilograms) divided by length (in meters), squared.
5Values are adjusted means (95% CI), n= 286. Adjusted means in a rowwithout a common letter are significantly different (Tukey–Kramer test, P< 0.05). Groups were compared
by using general linear models that adjusted for month of enrollment, cluster, age, sex, and value of the outcome variable at baseline.
showing that the %FM measurements as determined by 2H2O
were comparable with those obtained by BIA in a subgroup
of 190 study participants. Furthermore, other investigators
have confirmed that the 2H2O procedure is an appropriate
methodology for the assessment of BC in children with
MAM (23).
Our finding of a greater increase in body weight and WLZ
among children who received RUSF extends the main finding
from the parent study (10). In a recent trial involving children
with MAM from Burkina Faso, Fabiansen et al. (20) also
reported greater gains in body weight, WLZ, MUAC, and
overall recovery rates among children who received LNS for
TABLE 4 Change in anthropometric status and body composition from baseline to the end of the 12-wk intervention according to
recovery status at end of treatment1
Recovered at end of
treatment (n= 182)
Not recovered at end of
treatment (n= 104) P value
Length, cm 2.99 (2.84, 3.14) 2.31 (2.11, 2.51) <0.0001
Body weight, kg 1.28 (1.22, 1.35) 0.59 (0.50, 0.67) <0.0001
Total body water, kg 0.61 (0.56, 0.66) 0.33 (0.26, 0.40) <0.0001
FFM, kg 0.80 (0.74, 0.87) 0.44 (0.36, 0.53) <0.0001
FFMI,2 kg/m2 0.69 (0.58, 0.81) 0.27 (0.12, 0.41) <0.0001
FM, kg 0.51 (0.45, 0.57) 0.05 (–0.02, 0.13) <0.0001
FMI,3 kg/m2 0.57 (0.46, 0.68) –0.13 (–0.27, 0.01) <0.0001
FM, % of body weight 1.32 (0.65, 1.99) –1.19 (–2.07, –0.32) <0.0001
Weight-for-length z score 1.08 (1.00, 1.16) 0.15 (0.04, 0.56) <0.0001
Weight-for-age z score 0.85 (0.79, 0.92) 0.07 (–0.02, 0.16) <0.0001
Length-for-age z score 0.07 (0.01, 0.12) –0.18 (–0.25, –0.11) <0.0001
MUAC, cm 1.20 (1.13, 1.27) 0.27 (0.17, 0.37) <0.0001
1Values are mean (95% CI), n = 286. Change from baseline to final was compared according to recovery status using a mixed linear regression model that adjusted for the value
of the outcome variable at baseline, age, sex, cluster, and month of enrollment. “Recovery” was defined as a weight-for-height z score ≥ −2 and a MUAC ≥12.5 cm at the end
of the 12-wk dietary treatment. FFM, fat-free mass; FFMI, fat-free mass index; FM, fat mass; FMI, fat mass index; MUAC, mid-upper arm circumference.
2FFMI was calculated as FFM (in kilograms) divided by length (in meters), squared.
3FMI was calculated as FM (in kilograms) divided by length (in meters), squared.
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12 wk in comparison with CSB. However, in contrast to our
findings, which illustrated a significantly greater increase in FM,
independent of length accrual, among children who received
RUSF compared with MI, the Burkinabe children receiving
LNS exhibited a slight increase in FFMI in comparison with
those receiving CSB. Furthermore, although the mean amount
of weight gained over the 12-wk intervention period was similar
in both studies (1.01 kg in our study compared with 0.90 kg
in the Burkina study), the composition of the accrued mass
was quite different. Of the mean mass accrued by children
in our study, ∼31% was in the form of FM. This value is
somewhat lower than the range of 40–46% of mass accrued as
fat in Peruvian and Indian children recovering from SAM (24,
25). However, the corresponding proportion in the Burkinabe
children with MAM was only 6.7%, which resembles the
proportion of body weight accrued as fat during normal growth
in well-nourished children (19). Fabiansen et al. (20) speculated
that the relatively higher proportion of fat accrual in the
older studies of children with SAM could be due to a diet
that was inadequate in zinc and other micronutrients that are
critical for growth and FFM accrual. Although all 4 dietary
supplements in our study met WHO recommendations for the
nutrient contents of rehabilitation diets (9, 26), it is possible
that underlying infection could have diverted essential nutrients
typically used for FFM synthesis and caused the subsequent
deposition of excess energy as fat. Alternatively, the greater
proportionate gain in FM by children recovering from SAM
may be because they start out with lower %FM than those with
MAM, especially when the diagnosis of SAM is based on the
presence of edema. Although there was no association between
%FM at baseline and recovery status in our study population,
there was an inverse association between %FM at baseline and
change in %FM over the intervention period. However, it is
possible that the latter observation could reflect regression to
the mean due to imprecision of the measurements.
Breastfeeding status, history of malnutrition, and zinc status
have all been suggested to play a role in tissue accrual or BC
status (27–29). Unfortunately, we did not have comprehensive
data on these factors in our population, nor are they consistently
reported in other study populations. It is also possible that the
hydration coefficient of FFM in well-nourished children may
not be valid for use in children with AM. Boutton et al. (27)
have reported that the relatively high weight-for-height values
observed in a group of stunted Peruvian children were not
reflective of increased FM, but rather increased hydration of
FFM in the form of extracellular water, in comparisonwith well-
nourished children. Clearly, more research is needed to better
understand the biological mechanisms governing BC and the
partitioning of tissue accrual, as well as possible methodological
factors that may explain the diversity in BC data from various
populations.
The utility of BC assessment in the context of CMAM
programs is difficult to assess based on the findings from our
study. Based on previous studies involving children with AM
(20, 22, 24, 25), we expected the %FM of this population of
children with MAM to be lower than that of healthy children
and that BC assessment would enable us to identify whether
and how effectively supplementation restored “reference”
BC as children recovered. Although we observed significant
differences in all BC parameters according to recovery status
at the end of the 12-wk intervention, our inability to detect any
significant differences in %FM across intervention groups using
the 2H2O dilution method indicates that BC measurements may
not be sufficiently sensitive to compare the nutritional adequacy
of different therapeutic diets even in a research setting.
Several strengths of our study should be noted. Despite its
challenges, we assessed BC using the 2H2O dilution technique,
which is considered the best available method for field use.
We also implemented multivariate statistical modeling in our
analysis of the data to account for the effects of important
covariates such as age, sex, baseline BC, and seasonality.
Furthermore, our study provides much-needed data from an
understudied, but very important, population: young children
with MAM. However, our study was not free from limitations.
First, although our sample size of 286 is one of the largest
to date, we did not achieve our goal of 102 children per
group (i.e., 408 total), which reduced our ability to detect
a possible small difference in %FM between groups. This
was primarily due to the difficulty in obtaining adequate
postdose saliva samples from young children living in an
arid environment with extremely high temperatures. Second,
logistical constraints prevented us from randomly selecting
participants for this substudy from the larger parent trial, which
resulted in some differences between groups at baseline and
limits the generalizability of our findings. Children enrolled
in the substudy attended the 8 CSComs that were closest
to the district hospital and may have had better access to
medical services. The mean LAZ and WAZ at baseline were
also slightly higher among children enrolled in the BC substudy
than among those who were not enrolled, indicating a better
nutritional status at baseline. Third, we evaluated the change
in BC from enrollment to the end of the 12-wk intervention
period in all children. We did not evaluate the change in
BC from enrollment to the actual time of recovery. This
is an important distinction because supplementation would
stop and children would “graduate” from the treatment
program once their WLZ and MUAC surpassed thresholds
of –2 and 12.5 cm, respectively, in an actual programmatic
setting. This may have attenuated differences between groups.
Finally, the diversity of the participants’ age at baseline (6–
35 mo of age) and the corresponding variability in the
expected BC trajectory over the 12-wk intervention period
make it difficult to compare our findings with those of other
studies.
In conclusion, supplementation with RUSF resulted in a
greater increase in body weight, absolute FM, and WLZ among
Malian children with MAM in comparison with a locally
produced, less refined, micronutrient-fortified cereal–legume
blend. Although no differences in %FMwere observed between
groups, children who recovered from MAM at the end of
the 12-wk intervention did exhibit a larger increase in %FM,
along with all other BC parameters than children who had not
recovered. International BC reference data and further research
on the physiological mechanisms underpinning BC changes in
malnourished populations are urgently needed before the utility
of BC assessment in CMAM programs can be comprehensively
assessed.
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